Sargent Investment Group, LLC Coherus Bio Sciences, Inc. Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

A detailed history of Sargent Investment Group, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 43,130 shares of CHRS stock, worth $31,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,130

Previous 43,130 -0.0%

Holding current value

$31,916

Previous $74,000 40.54%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.58 - $2.51 $8,800 - $13,980	-5,570 Reduced 11.44%	43,130 $74,000
Q1 2024 May 10, 2024	BUY	$2.02 - $3.14 $45,732 - $71,089	22,640 Added 86.88%	48,700 $116,000
Q4 2023 Feb 05, 2024	BUY	$1.59 - $3.85 $10,125 - $24,516	6,368 Added 32.34%	26,060 $86,000
Q2 2023 Jul 31, 2023	BUY	$3.79 - $8.3 $74,632 - $163,443	19,692 New	19,692 $84,000
Q4 2022 Jan 31, 2023	SELL	$5.69 - $10.07 $22,589 - $39,977	-3,970 Reduced 26.17%	11,200 $88,000
Q3 2022 Oct 26, 2022	SELL	$7.17 - $13.87 $45,565 - $88,143	-6,355 Reduced 29.52%	15,170 $148,000
Q2 2022 Jul 26, 2022	SELL	$5.86 - $13.23 $29,915 - $67,539	-5,105 Reduced 19.17%	21,525 $156,000
Q1 2022 May 06, 2022	SELL	$10.92 - $16.41 $143,095 - $215,036	-13,104 Reduced 32.98%	26,630 $344,000
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $107,602 - $129,245	-6,806 Reduced 14.62%	39,734 $634,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $649,152 - $910,759	-51,195 Reduced 52.38%	46,540 $748,000
Q2 2021 Aug 05, 2021	SELL	$12.95 - $15.41 $87,386 - $103,986	-6,748 Reduced 6.46%	97,735 $1.35 Million
Q1 2021 May 04, 2021	BUY	$14.42 - $21.39 $97,176 - $144,147	6,739 Added 6.89%	104,483 $1.53 Million
Q4 2020 Feb 10, 2021	SELL	$16.56 - $18.94 $134,003 - $153,262	-8,092 Reduced 7.65%	97,744 $1.7 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $255,160 - $291,507	14,656 Added 16.07%	105,836 $1.94 Million
Q2 2020 Aug 11, 2020	BUY	$14.43 - $19.16 $137,157 - $182,115	9,505 Added 11.64%	91,180 $1.66 Million
Q1 2020 May 12, 2020	BUY	$11.67 - $22.53 $203,291 - $392,472	17,420 Added 27.11%	81,675 $1.33 Million
Q4 2019 Jan 30, 2020	BUY	$16.33 - $21.37 $371,017 - $485,526	22,720 Added 54.7%	64,255 $1.16 Million
Q3 2019 Oct 29, 2019	BUY	$16.3 - $23.37 $406,196 - $582,380	24,920 Added 149.98%	41,535 $841,000
Q2 2019 Aug 12, 2019	BUY	$13.1 - $22.1 $217,656 - $367,191	16,615 New	16,615 $367,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account

Sargent Investment Group, LLC Coherus Bio Sciences, Inc. Transaction History